Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

SomnoMed Limited (SOMNF)

0.3900
0.0000
(0.00%)
At close: April 25 at 4:00:00 PM EDT
Loading Chart for SOMNF
  • Previous Close 0.0000
  • Open 0.3750
  • Bid 0.2255 x --
  • Ask 0.3055 x 301800
  • Day's Range 0.3675 - 0.3750
  • 52 Week Range 0.1300 - 0.4400
  • Volume 4,500
  • Avg. Volume 195
  • Market Cap (intraday) 84.282M
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date Jul 21, 2025 - Jul 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. In addition, it provides Sunrise, a bio-signal to diagnose sleep apnea. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

somnomed.com/au/

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: SOMNF

View More

Performance Overview: SOMNF

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

SOMNF
129.41%
S&P/ASX 200 [XJO] (^AXJO)
2.34%

1-Year Return

SOMNF
200.00%
S&P/ASX 200 [XJO] (^AXJO)
3.71%

3-Year Return

SOMNF
66.67%
S&P/ASX 200 [XJO] (^AXJO)
6.62%

5-Year Return

SOMNF
47.30%
S&P/ASX 200 [XJO] (^AXJO)
51.99%

Compare To: SOMNF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SOMNF

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    57.76M

  • Enterprise Value

    49.75M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.00

  • Price/Book (mrq)

    2.76

  • Enterprise Value/Revenue

    0.78

  • Enterprise Value/EBITDA

    25.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.98%

  • Return on Assets (ttm)

    -2.14%

  • Return on Equity (ttm)

    -15.51%

  • Revenue (ttm)

    100.25M

  • Net Income Avi to Common (ttm)

    -6M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.5M

  • Total Debt/Equity (mrq)

    12.45%

  • Levered Free Cash Flow (ttm)

    923.07k

Research Analysis: SOMNF

View More

Company Insights: SOMNF

Research Reports: SOMNF

View More

People Also Watch